Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery

Objective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation. Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient&#...

Full description

Bibliographic Details
Main Authors: Ümit Arslan, Mehmet Erdem Memetoğlu, Rasim Kutlu, Ozan Erbasan, Mehmet Tort, Eyüp Serhat Çalık, Ziya Yıldız, M. Ali Kaygın, Ozan Erdem, Ali İhsan Tekin
Format: Article
Language:English
Published: Limited liability company «Science and Innovations» (Saratov) 2015-05-01
Series:Russian Open Medical Journal
Subjects:
Online Access:http://www.romj.org/node/125
id doaj-2c2c61df8d3b4f81b8d8feb6016dcfab
record_format Article
spelling doaj-2c2c61df8d3b4f81b8d8feb6016dcfab2021-10-06T12:15:47ZengLimited liability company «Science and Innovations» (Saratov)Russian Open Medical Journal2304-34152015-05-0142e020410.15275/rusomj.2015.0204Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgeryÜmit ArslanMehmet Erdem MemetoğluRasim KutluOzan ErbasanMehmet TortEyüp Serhat ÇalıkZiya YıldızM. Ali KaygınOzan ErdemAli İhsan TekinObjective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation. Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient's medical record was retrospectively reviewed. The patients who were included in the study were evaluated in groups of 60. One group was comprised of nondiabetic patients, whose HbA1c level is below 6% (the control group 0), the other included diabetic patients with the HbA1c level is between 6-6.9% (the group 1) and the last group, group 2, included those patients with HbA1c level is equal or greater than 7%. Pre, peri and post operation data was compared. The deaths that occured in the first 30 days were evaluated as mortality and complications as morbitity. Results ― While mortality was not observed in the control group, one incident was observed in group 1 and 5 in group 2, which corresponds to 1.7% and 8.3% respectively. The mortality ratio in the group with patients whose HbA1c was greater or equal to 7% found statistically significant compared to the control group (P=0.02). The following parameters were observed in group 2 and were found statistically significant: the need for dialisis (25%, P<0.01), atrial fibrillation (33%, P=0.01), revision due to bleeding (10%, P=0.18), cerebrovascular event (16,7%, P=0.01), duration of mechanic ventilation (19.5±21.6, P=0.06), duration of hospital stay (approximately 9.91±5.35 days, P=0.01), infection in scar (53%, P<0.01), mediastenit (11%, P=0.01) and urinary tract infection (10%, P=0.01) Conclusion ― We concluded that in those diabetic patients that elective coronart artery bypass graft is applied, highly reactive HbA1c levels (HbA1c ≥7), may indicate morbitity in the early stages of post operation.http://www.romj.org/node/125diabetes mellitusHbA1ccoronary artery bypass operationmorbiditymortality
collection DOAJ
language English
format Article
sources DOAJ
author Ümit Arslan
Mehmet Erdem Memetoğlu
Rasim Kutlu
Ozan Erbasan
Mehmet Tort
Eyüp Serhat Çalık
Ziya Yıldız
M. Ali Kaygın
Ozan Erdem
Ali İhsan Tekin
spellingShingle Ümit Arslan
Mehmet Erdem Memetoğlu
Rasim Kutlu
Ozan Erbasan
Mehmet Tort
Eyüp Serhat Çalık
Ziya Yıldız
M. Ali Kaygın
Ozan Erdem
Ali İhsan Tekin
Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
Russian Open Medical Journal
diabetes mellitus
HbA1c
coronary artery bypass operation
morbidity
mortality
author_facet Ümit Arslan
Mehmet Erdem Memetoğlu
Rasim Kutlu
Ozan Erbasan
Mehmet Tort
Eyüp Serhat Çalık
Ziya Yıldız
M. Ali Kaygın
Ozan Erdem
Ali İhsan Tekin
author_sort Ümit Arslan
title Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
title_short Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
title_full Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
title_fullStr Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
title_full_unstemmed Preoperative Hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
title_sort preoperative hba1c level in prediction of short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery
publisher Limited liability company «Science and Innovations» (Saratov)
series Russian Open Medical Journal
issn 2304-3415
publishDate 2015-05-01
description Objective ― This study was conducted to determine whether HbA1c is a predictor of short term mortality and morbidity after coronary artery bypass graft operation. Methods ― The coronary artery bypass graft operation was performed on the patients between January 2009 and January 2013. Each patient's medical record was retrospectively reviewed. The patients who were included in the study were evaluated in groups of 60. One group was comprised of nondiabetic patients, whose HbA1c level is below 6% (the control group 0), the other included diabetic patients with the HbA1c level is between 6-6.9% (the group 1) and the last group, group 2, included those patients with HbA1c level is equal or greater than 7%. Pre, peri and post operation data was compared. The deaths that occured in the first 30 days were evaluated as mortality and complications as morbitity. Results ― While mortality was not observed in the control group, one incident was observed in group 1 and 5 in group 2, which corresponds to 1.7% and 8.3% respectively. The mortality ratio in the group with patients whose HbA1c was greater or equal to 7% found statistically significant compared to the control group (P=0.02). The following parameters were observed in group 2 and were found statistically significant: the need for dialisis (25%, P<0.01), atrial fibrillation (33%, P=0.01), revision due to bleeding (10%, P=0.18), cerebrovascular event (16,7%, P=0.01), duration of mechanic ventilation (19.5±21.6, P=0.06), duration of hospital stay (approximately 9.91±5.35 days, P=0.01), infection in scar (53%, P<0.01), mediastenit (11%, P=0.01) and urinary tract infection (10%, P=0.01) Conclusion ― We concluded that in those diabetic patients that elective coronart artery bypass graft is applied, highly reactive HbA1c levels (HbA1c ≥7), may indicate morbitity in the early stages of post operation.
topic diabetes mellitus
HbA1c
coronary artery bypass operation
morbidity
mortality
url http://www.romj.org/node/125
work_keys_str_mv AT umitarslan preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT mehmeterdemmemetoglu preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT rasimkutlu preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT ozanerbasan preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT mehmettort preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT eyupserhatcalık preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT ziyayıldız preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT malikaygın preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT ozanerdem preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
AT aliihsantekin preoperativehba1clevelinpredictionofshorttermmorbidityandmortalityoutcomesfollowingcoronaryarterybypassgraftingsurgery
_version_ 1716840828764160000